Semaglutide has rapidly emerged as one of the most transformative medications in the treatment of type 2 diabetes and obesity, with significant benefits for cardiovascular health. A member of the GLP-1 receptor agonist class, Semaglutide mimics the natural hormone glucagon-like peptide-1 (GLP-1) in the body, which plays a vital role https://holdenycehj.wikicommunications.com/4954227/semaglutide_a_breakthrough_in_managing_diabetes_weight_and_heart_health